blood specimen
Sponsors
M.D. Anderson Cancer Center, Icahn School of Medicine at Mount Sinai, University of Miami, Centre Hospitalier Universitaire de Saint Etienne, Royal Marsden NHS Foundation Trust
Conditions
AniridiaAxial SpondyloarthritisCancerCancer SurvivorCrohn's DiseaseEssential ThrombocythemiaGranulomatosis, Wegener'sHemophilia
Phase 4
Unknown Phase
Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
NCT00503893
Start: 1980-12-01End: 2020-12-31Updated: 2020-01-27
Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients
CompletedNCT01970930
Start: 2012-08-31End: 2016-06-02Updated: 2018-01-19
Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors
CompletedNCT02032121
Start: 2007-10-31End: 2015-08-31Updated: 2015-09-09
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis
TerminatedNCT02474888
Start: 2015-09-15End: 2020-06-12Updated: 2020-11-16
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort
CompletedNCT02502552
Start: 2013-11-30End: 2015-10-31Updated: 2015-11-02
Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism
CompletedNCT02524041
Start: 2014-03-31End: 2016-04-30Updated: 2016-05-25
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
CompletedNCT02540187
Start: 2012-02-29End: 2016-02-29Updated: 2016-03-10
Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology
CompletedNCT02549248
Start: 2012-12-31End: 2015-04-30Updated: 2015-09-15
'Lung Health Check' Biomarker Study
NCT04957433
Start: 2020-09-28End: 2023-12-01Target: 1000Updated: 2022-07-18
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
WithdrawnNCT05287347
Start: 2022-01-01End: 2024-12-03Updated: 2025-05-25
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
RecruitingNCT05964504
Start: 2023-12-20End: 2036-02-28Target: 12Updated: 2026-03-17